Literature DB >> 17514488

Inhibition of influenza viral neuraminidase activity by collectins.

T Tecle1, M R White, E C Crouch, K L Hartshorn.   

Abstract

The collectins, lung surfactant proteins A and D (SP-A and SP-D), contribute to innate host defense against influenza A virus (IAV) in vivo. Although collectins bind to the viral hemagglutinin (HA) and inhibit early stages of viral infection in vitro, they also bind to the neuraminidase (NA) and inhibit NA activity. We used a variety of NA functional assays, viral strains and recombinant (mutant or wild type) collectins to characterize the mechanism of NA inhibition. NA inhibition by SP-D correlates with binding of its carbohydrate recognition domain (CRD) to oligomannose oligosaccharides on the viral hemagglutinin (HA). The effects of SP-D are additive with oseltamivir, consistent with differences in mechanism of action. NA inhibition was observed using fetuin or MDCK cells as a substrate, but not in assays using a soluble sialic acid analogue. Collectin multimerization and CRD binding properties are key determinants for NA inhibition. SP-D had greater NA inhibitory activity than mannose-binding lectin, which in turn had greater activity than SP-A. The markedly greater NA inhibitory activity of SP-D compared to SP-A may partly account for the finding that deletion of the SP-D gene in mice has a greater effect on viral replication in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514488     DOI: 10.1007/s00705-007-0983-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Viral aggregating and opsonizing activity in collectin trimers.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Grith Sorensen; Uffe Holmskov; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

2.  Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.

Authors:  David Groeger; Elisa Schiavi; Ray Grant; Magdalena Kurnik-Łucka; David Michalovich; Rick Williamson; Soren Beinke; Barry Kiely; Cezmi A Akdis; Edith M Hessel; Fergus Shanahan; Liam O' Mahony
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

3.  Multiple components contribute to ability of saliva to inhibit influenza viruses.

Authors:  M R White; E J Helmerhorst; A Ligtenberg; M Karpel; T Tecle; W L Siqueira; F G Oppenheim; K L Hartshorn
Journal:  Oral Microbiol Immunol       Date:  2009-02

4.  Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.

Authors:  Erika Crouch; Kevan Hartshorn; Tim Horlacher; Barbara McDonald; Kelly Smith; Tanya Cafarella; Barbara Seaton; Peter H Seeberger; James Head
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

5.  Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.

Authors:  Nikolaos M Nikolaidis; Mitchell R White; Kimberly Allen; Shweta Tripathi; Li Qi; Barbara McDonald; Jeffery Taubenberger; Barbara A Seaton; Francis X McCormack; Erika C Crouch; Kevan L Hartshorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-04       Impact factor: 5.464

6.  Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Authors:  Emma R Job; Barbara Bottazzi; Brad Gilbertson; Kathryn M Edenborough; Lorena E Brown; Alberto Mantovani; Andrew G Brooks; Patrick C Reading
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 7.  New treatments for influenza.

Authors:  Sailen Barik
Journal:  BMC Med       Date:  2012-09-13       Impact factor: 8.775

8.  Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.

Authors:  Marine L B Hillaire; Martin van Eijk; Stella E van Trierum; Debby van Riel; Xavier Saelens; Roland A Romijn; Wieger Hemrika; Ron A M Fouchier; Thijs Kuiken; Albert D M E Osterhaus; Henk P Haagsman; Guus F Rimmelzwaan
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

Review 9.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

10.  Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.

Authors:  Kevan L Hartshorn; Richard Webby; Mitchell R White; Tesfaldet Tecle; Clark Pan; Susan Boucher; Rodney J Moreland; Erika C Crouch; Ronald K Scheule
Journal:  Respir Res       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.